DRUG-INDUCED CHANGES IN RELEASE OF H-3 NORADRENALINE FROM FIELD STIMULATED RAT IRIS

[1] AXELROD J, 1966, PHARMACOL REV, V18, P95

[2] BALDESSA.RJ, 1967, J PHARMACOL EXP THER, V156, P31

[3] PHARMACOLOGICAL EXPERIMENTS ON RELEASE OF SYMPATHETIC TRANSMITTER [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1963, 167 (03): : 505 - &

[4] CARDIOVASCULAR EFFECTS OF 2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HYDROCHLORIDE (ST 155) .I. PERIPHERAL SYMPATHETIC SYSTEM [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1968, 2 (05) : 333 - &

[5] BOULLIN DJ, 1967, J PHARMACOL EXP THER, V157, P125

[6] Brown G.L., 1964, P R SOC B, V162, P1

[7] BROWN GL, 1957, J PHYSIOL-LONDON, V138, P81, DOI 10.1113/jphysiol.1957.sp005839

[8] CARLSSON ARVID, 1966, HANDBUCH EXP PHARMAKOL, V19, P529

[9] EISENFELD AJ, 1967, J PHARMACOL EXP THER, V158, P378

[10] EULER US, 1956, NORADRENALINE

[1] AXELROD J, 1966, PHARMACOL REV, V18, P95

[2] BALDESSA.RJ, 1967, J PHARMACOL EXP THER, V156, P31

[3] PHARMACOLOGICAL EXPERIMENTS ON RELEASE OF SYMPATHETIC TRANSMITTER [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1963, 167 (03): : 505 - &

[4] CARDIOVASCULAR EFFECTS OF 2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HYDROCHLORIDE (ST 155) .I. PERIPHERAL SYMPATHETIC SYSTEM [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1968, 2 (05) : 333 - &

[5] BOULLIN DJ, 1967, J PHARMACOL EXP THER, V157, P125

[6] Brown G.L., 1964, P R SOC B, V162, P1

[7] BROWN GL, 1957, J PHYSIOL-LONDON, V138, P81, DOI 10.1113/jphysiol.1957.sp005839

[8] CARLSSON ARVID, 1966, HANDBUCH EXP PHARMAKOL, V19, P529

[9] EISENFELD AJ, 1967, J PHARMACOL EXP THER, V158, P378

[10] EULER US, 1956, NORADRENALINE